GENOUS Trademark
GENOUS is a USPTO trademark filed by GENOMATE HEALTH INC.. Status: Pending.
Trademark Facts
| Mark | GENOUS |
|---|---|
| Serial Number | 98755109 |
| Status | Pending |
| Filing Date | 2024-09-17 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT), 044 (Medical Services) |
| Owner | GENOMATE HEALTH INC. |
| Attorney of Record | Sudip K. Mitra |
| Prosecution Events | 25 |
| Latest Event | XELR on 2026-03-05 |
Goods & Services
Genetic testing for medical purposes, Genetic testing for cancer risk for medical purposes; Genetic testing for medical purposes for detecting genetic predispositions; Genetic counseling; Medical counseling for the medical treatment of genetic predispositions; Providing information about genetic counseling; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized therapy services, clinical decision support services and evidence-based treatment decisions; Consulting services in the field of health care to assist with biomedical and clinical decisions; medical diagnostic testing, monitoring and reporting services in personalized medicine; Biological research and analysis; Medical research services; Scientific research, namely scientific research relating to genetic alterations; Research in the field of genetic diseases; Consulting services in the field of genetic science; Genetic sequencing services for scientific and medical purposes; Providing medical research information in the field of genetics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing for disease, treatment, trial, outcome and molecular diagnostic test results for decision support